PMCB PharmaCyte Biotech, Inc. - Common Stock
$0.53
价格 · 八月 19, 2026
截至...的财报数据 七月 29, 2026
PMCB 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$0.53
市值
$6M
P/E (TTM)
-0.2
每股收益 (TTM)
$-2.77
营收 (TTM)
$0
股息收益率
—
ROE
-56.7%
负债/权益
—
52周区间
$1 – $2
PMCB 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
Configure
10年表现 收入、净利润、利润率和每股收益趋势
营收与净利润
$0
2017-04-30
→
2026-04-30
EPS
$-2.77
2021-04-30
→
2026-04-30
自由现金流
—
利润率
—
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜?
指标
5年趋势
PMCB
同行中位数
P/E (TTM)
-0.2
—
P/B (市净率)
0.2
1.0
盈利能力 毛利率、营业利润率和净利率;股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
指标
5年趋势
PMCB
同行中位数
ROA
-38.1%
-105.1%
ROE
-56.7%
-142.1%
财务健康 债务、流动性、偿付能力 — 资产负债表强度
指标
5年趋势
PMCB
同行中位数
Current Ratio (流动比率)
45.3
1.6
Quick Ratio (速动比率)
22.8
—
成长 营收、每股收益 (EPS) 和净利润增长:同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
指标
5年趋势
PMCB
同行中位数
Net Income YoY (净利润同比增长)
9085.0%
—
资本效率 资产周转率、库存周转率、应收账款周转率
指标
5年趋势
PMCB
同行中位数
PMCB 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
卖出
6 位分析师
- 强烈买入 0 0.0%
- 买入 0 0.0%
- 持有 3 50.0%
- 卖出 1 16.7%
- 强烈卖出 2 33.3%
收益历史 每股收益实际值 vs 预估值,惊喜%,达标率,下次财报日期
下次报告
九月 14, 2026
| 期间 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|
| 2026年3月31日 | $-0.09 | — | — |
| 2025年9月30日 | $-0.10 | — | — |
| 2025年6月30日 | $-0.29 | — | — |
| 2025年3月31日 | $0.14 | — | — |
同行比较(GICS 子行业) 关键指标与行业同行对比
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| PMCB | $8M | -0.3 | — | — | -56.7% | — |
| ERNA | — | — | — | — | — | — |
| ENSC | $4M | -0.2 | -2.8% | -200.9% | -294.0% | — |
| BOLT | $11M | -0.3 | 0.07% | -433.7% | -102.2% | — |
| CDIO | — | — | — | — | — | — |
| ACXP | $6M | -0.5 | — | — | -180.3% | — |
| BRTX | $10M | -0.7 | -10.3% | -3959.4% | -547.6% | 93.4% |
| XBIO | — | -1.4 | 19.0% | — | — | — |
| DRMA | — | — | — | — | — | — |
| GOVX | $296.2K | — | -37.1% | -862.3% | -645.9% | — |
| LABT | — | — | — | — | — | — |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表 16
| 指标 | 趋势 | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Cost of Revenue | · | · | · | · | · | · | · | · | · | · | $0 | $0 | |
| Gross Profit | · | · | · | · | · | · | · | · | · | · | $0 | $0 | |
| R&D Expense | $391.3K | $438.4K | $407.4K | $468.5K | $690.9K | $916.2K | $301.2K | $460.1K | $2M | $1M | $1M | $3M | |
| SG&A Expense | $5M | $4M | $6M | $1M | $1M | $418.1K | $1M | $1M | $2M | $744.8K | $2M | $2M | |
| Operating Expenses | $7M | $4M | $9M | $6M | $4M | $4M | $4M | $4M | $7M | $4M | $6M | $13M | |
| Operating Income | $-7M | $-4M | $-9M | $-6M | $-4M | $-4M | $-4M | $-4M | $-7M | $-4M | $-6M | $-13M | |
| Interest Expense | · | · | · | $0 | $509 | $3.0K | $453 | $0 | $0 | $1.5K | $1.2K | $4.9K | |
| Other Non-op | $-980 | $-965 | $191.1K | $202.0K | $-4.3K | $71.7K | $-493 | $33.4K | $152.6K | $-1.5K | $9.3K | $3M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-19M | $31M | $333.8K | $-4M | $-4M | $-4M | $-4M | $-4M | $-7M | $-4M | $-6M | $-10M | |
| EPS (Basic) | $-2.77 | $3.19 | $-1.80 | $-0.22 | $-0.27 | $-2.45 | · | · | · | · | · | · | |
| EPS (Diluted) | $-2.77 | $3.19 | $-1.80 | $-0.22 | $-0.27 | $-2.45 | · | · | · | · | · | · | |
| Shares (Basic) | 8,378,291 | 7,329,596 | 9,581,059 | 19,489,204 | 15,521,654 | 1,448,285 | 903,812 | 1,100,104,338 | 968,641,686 | 845,308,413 | 752,403,049 | 704,327,656 | |
| Shares (Diluted) | 8,378,291 | 7,329,596 | 9,581,059 | 19,489,204 | 15,521,654 | 1,448,285 | 903,812 | 1,100,104,338 | 968,641,686 | 845,308,413 | 752,403,049 | 704,327,656 | |
| EBITDA | $-7M | $-4M | $-9M | $-6M | $-4M | $-4M | $-4M | $-4M | $-7M | $-4M | $-6M | · |
资产负债表 19
| 指标 | 趋势 | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $19M | $15M | $50M | $68M | $85M | $2M | $894.9K | $515.3K | $1M | $3M | $2M | $3M | |
| Short-term Investments | $254.0K | $366.3K | $0 | · | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $96.9K | $223.8K | $259.8K | $107.7K | $94.2K | $73.1K | $142.8K | $138.2K | $224.1K | $74.3K | $110.0K | $1M | |
| Current Assets | $37M | $22M | $50M | $68M | $85M | $2M | $1M | $653.4K | $1M | $4M | $2M | $4M | |
| Intangibles | $0 | $2M | $2M | $4M | $4M | · | · | · | · | · | · | · | |
| Other Non-current Assets | $7.7K | $7.7K | · | · | · | $7.4K | $7.4K | $7.4K | $7.4K | $7.4K | $7.9K | $7.9K | |
| Total Assets | $47M | $55M | $60M | $73M | $91M | $7M | $6M | $6M | $6M | $9M | $7M | $9M | |
| Accounts Payable | $271.1K | $399.2K | $389.4K | $128.3K | $205.4K | $172.3K | $185.8K | $121.9K | $352.6K | $365.6K | $336.0K | $496.7K | |
| Accrued Liabilities | $522.8K | $3M | $735.2K | $458.3K | $499.0K | $552.5K | $816.6K | $621.0K | $291.5K | $214.6K | $151.6K | $23.7K | |
| Current Liabilities | $826.4K | $3M | $7M | $586.6K | $704.4K | $724.8K | $1M | $742.9K | $644.2K | $580.2K | $637.6K | $2M | |
| Total Liabilities | $12M | $3M | $20M | $586.6K | $704.4K | $724.8K | $1M | $742.9K | $644.2K | $580.2K | $637.6K | $2M | |
| Common Stock | $2.6K | $2.2K | $2.2K | $2.2K | $2.1K | $159 | $109 | $118.6K | $101.3K | $90.5K | $78.1K | $73.3K | |
| Paid-in Capital | $183M | $181M | $185M | $202M | $202M | $114M | $109M | $105M | $102M | $97M | $91M | $86M | |
| Retained Earnings | $-104M | $-85M | $-116M | $-116M | $-112M | $-107M | $-104M | $-100M | $-96M | $-89M | $-85M | $-79M | |
| Treasury Stock | $45M | $45M | $42M | $14M | $0 | · | · | · | · | · | · | · | |
| AOCI | $-20.8K | $-23.9K | $-23.5K | $-23.0K | $-15.8K | $-20.4K | $-21.7K | $-13.8K | $-4.7K | $1.7K | $806 | $1.5K | |
| Stockholders' Equity | $33M | $52M | $28M | $73M | $90M | $7M | $5M | $5M | $6M | $8M | $7M | $8M | |
| Liabilities + Equity | $47M | $55M | $60M | $73M | $91M | $7M | $6M | $6M | $6M | $9M | $7M | $9M | |
| Shares Outstanding | 10,735,649 | 6,795,779 | 8,037,624 | 16,793,980 | 20,721,047 | 1,590,084 | 1,092,425 | 1,186,004,505 | 1,013,260,644 | 905,349,047 | 781,233,338 | 732,760,536 |
现金流 9
| 指标 | 趋势 | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $892.5K | $0 | $674.7K | $7.3K | $33.1K | $194.3K | $368.6K | $293.3K | $580.4K | $420.5K | $405.1K | $735.2K | |
| Operating Cash Flow | $-5M | $-3M | $-2M | $-4M | $-4M | $-3M | $-2M | $-3M | $-5M | $-3M | $-4M | $-5M | |
| Investing Cash Flow | $2M | $-7M | $-5M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | · | |
| Stock Issued | · | · | · | $0 | $87M | $5M | $3M | $2M | $3M | $5M | $4M | $4M | |
| Stock Repurchased | $401.6K | $3M | $28M | $14M | $0 | · | · | · | · | · | · | · | |
| Net Stock Activity | $-401.6K | $-3M | $-28M | $-14M | $87M | $5M | $3M | $2M | $3M | $5M | $4M | · | |
| Financing Cash Flow | $7M | $-25M | $-11M | $-14M | $87M | $5M | $3M | $2M | $3M | $5M | · | · | |
| Net Change in Cash | $3M | $-35M | $-18M | $-17M | $83M | $1M | $379.6K | · | · | · | · | · | |
| Taxes Paid | $0 | $0 | $1.6K | $0 | $1.6K | $800 | $800 | $800 | $800 | $800 | · | · |
盈利能力 2
| 指标 | 趋势 | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -38.1% | 53.3% | 0.50% | -5.3% | -8.6% | -52.3% | -64.0% | -66.7% | -90.6% | -56.1% | -73.7% | · | |
| ROE | -56.7% | 66.5% | 1.1% | -5.8% | -4.7% | -49.7% | -81.3% | -78.2% | -117.7% | -60.8% | -84.8% | · |
流动性与偿付能力 3
| 指标 | 趋势 | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 45.3 | 7.7 | 6.8 | 116.2 | 121.4 | 3.1 | 1.0 | 0.9 | 2.0 | 6.1 | 3.2 | · | |
| Quick Ratio | 22.8 | 5.3 | 6.8 | 116.0 | 121.2 | 3.0 | 0.9 | 0.7 | 1.6 | 6.0 | 3.0 | · | |
| Interest Coverage | · | · | · | · | -8628.7 | -1189.4 | -8446.8 | · | · | -2886.4 | -5099.2 | · |
效率 1
| 指标 | 趋势 | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | · |
增长率 1
| 指标 | 趋势 | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income YoY | · | 9085.0% | · | · | · | · | · | · | · | · | · | · |
估值 (TTM) 8
| 指标 | 趋势 | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income TTM | $-19M | $31M | $333.8K | $-4M | $-4M | $-4M | $-4M | $-4M | $-7M | $-4M | $-6M | $-10M | |
| Market Cap | $8M | $8M | $17M | $49M | $4M | $44M | $62.23B | $75.37B | $84.81B | $109.32B | $82.95B | · | |
| P/E | -0.3 | 0.4 | -1.2 | -13.3 | -8.6 | -11.2 | · | · | · | · | · | · | |
| P/B | 0.2 | 0.2 | 0.6 | 0.7 | 0.0 | 6.5 | 12227.9 | 14955.8 | 14701.8 | 13517.1 | 12716.8 | · | |
| P / Tangible Book | 0.2 | 0.2 | 0.7 | 0.7 | 0.0 | 6.5 | 12227.9 | · | · | · | · | · | |
| P / Cash Flow | -1.5 | -2.8 | -7.9 | -12.9 | -0.9 | -13.1 | -26611.4 | -26189.3 | -16696.9 | -32734.7 | -19084.1 | · | |
| Earnings Yield | -383.7% | 257.3% | -84.9% | -7.5% | -11.6% | -8.9% | · | · | · | · | · | · |
损益表 13
| 指标 | 趋势 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| R&D Expense | $61.9K | $93.1K | $141.1K | $95.2K | $126.7K | $118.2K | $97.5K | $96.0K | $94.2K | $126.7K | $82.0K | $104.5K | $85.9K | $45.4K | $178.0K | $159.3K | |
| SG&A Expense | $899.9K | $2M | $1M | $753.1K | $915.9K | $842.1K | $1M | $1M | $4M | $251.9K | $272.5K | $1M | $328.1K | $356.9K | $183.0K | $244.7K | |
| Operating Expenses | $3M | $2M | $1M | $848.3K | $1M | $960.3K | $1M | $1M | $3M | $2M | $1M | $2M | $903.3K | $2M | $2M | $2M | |
| Operating Income | $-3M | $-2M | $-1M | $-848.3K | $-1M | $-960.3K | $-1M | $-1M | $-3M | $-2M | $-1M | $-2M | $-903.3K | $-2M | $-2M | $-2M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | |
| Other Non-op | $-132 | $-632 | $-95 | $-121 | $687 | $-400 | $-1.1K | $-190 | $194.0K | $-253 | $-765 | $-1.8K | $54.0K | $153.0K | $-1.1K | $-3.9K | |
| Net Income | $-4M | $746.9K | $-7M | $-8M | $12M | $-3M | $-1M | $23M | $1M | $-619.5K | $3M | $-3M | $-126.3K | $-764.1K | $-2M | $-2M | |
| EPS (Basic) | $-0.13 | $-0.17 | $-1.24 | $-1.23 | $2.12 | $-0.44 | $-0.39 | $1.90 | $-0.35 | $-0.65 | $-0.26 | $-0.54 | $-0.02 | $-0.04 | $-0.09 | $-0.07 | |
| EPS (Diluted) | $-0.13 | $-0.17 | $-1.24 | $-1.23 | $2.12 | $-0.44 | $-0.39 | $1.90 | $-0.35 | $-0.65 | $-0.26 | $-0.54 | $-0.02 | $-0.04 | $-0.09 | $-0.07 | |
| Shares (Basic) | -14,476,096 | 9,262,829 | 6,795,779 | 6,795,779 | -15,133,839 | 6,960,014 | 7,637,034 | 7,866,387 | -20,392,923 | 8,606,957 | 8,765,134 | 12,601,891 | -40,921,004 | 18,995,442 | 20,585,451 | 20,829,315 | |
| Shares (Diluted) | -14,476,096 | 9,262,829 | 6,795,779 | 6,795,779 | -15,133,839 | 6,960,014 | 7,637,034 | 7,866,387 | -20,392,923 | 8,606,957 | 8,765,134 | 12,601,891 | -40,921,004 | 18,995,442 | 20,585,451 | 20,829,315 | |
| EBITDA | · | $-2M | $-1M | $-848.3K | · | $-960.3K | $-1M | $-1M | · | $-2M | $-1M | $-2M | · | $-2M | $-2M | $-2M |
资产负债表 19
| 指标 | 趋势 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $19M | $20M | $15M | $13M | $15M | $16M | $21M | $33M | $50M | $61M | $73M | $75M | $68M | $73M | $77M | $82M | |
| Short-term Investments | $254.0K | $372.3K | $201.2K | $261.9K | $366.3K | $372.6K | · | · | $0 | · | · | · | · | · | · | · | |
| Prepaid Expense | $96.9K | $158.7K | $503.1K | $238.2K | $223.8K | $207.4K | $493.2K | $240.2K | $259.8K | $297.8K | $323.2K | $88.7K | $107.7K | $181.0K | $256.8K | $28.1K | |
| Current Assets | $37M | $21M | $23M | $19M | $22M | $17M | $21M | $33M | $50M | $62M | $74M | $75M | $68M | $73M | $77M | $82M | |
| Intangibles | $0 | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $4M | $4M | $4M | $4M | · | · | · | |
| Other Non-current Assets | $7.7K | · | · | · | $7.7K | · | · | · | · | · | · | · | · | · | · | · | |
| Total Assets | $47M | $56M | $56M | $45M | $55M | $44M | $55M | $70M | $60M | $71M | $79M | $80M | $73M | $78M | $82M | $87M | |
| Accounts Payable | $271.1K | $1M | $1M | $465.2K | $399.2K | $484.9K | $348.6K | $554.0K | $389.4K | $484.2K | $126.2K | $718.1K | $128.3K | $445.9K | $861.3K | $559.0K | |
| Accrued Liabilities | $522.8K | $445.7K | $520.7K | $595.7K | $3M | $709.4K | $707.2K | $684.1K | $735.2K | $774.4K | $1M | $480.0K | $458.3K | $381.9K | $449.9K | $530.3K | |
| Current Liabilities | $826.4K | $2M | $2M | $1M | $3M | $1M | $5M | $7M | $7M | $8M | $5M | $2M | $586.6K | $827.8K | $1M | $1M | |
| Total Liabilities | $12M | $16M | $19M | $2M | $3M | $4M | $12M | $17M | $20M | $22M | $21M | $20M | $586.6K | $827.8K | $1M | $1M | |
| Common Stock | $2.6K | $2.6K | $2.2K | $2.2K | $2.2K | $2.2K | $2.2K | $2.2K | $2.2K | $2.2K | $2.2K | $2.2K | $2.2K | $2.2K | $2.2K | $2.2K | |
| Paid-in Capital | $183M | $183M | $181M | $182M | $181M | $181M | $181M | $183M | $185M | $189M | $194M | $202M | $202M | $202M | $202M | $202M | |
| Retained Earnings | $-104M | $-100M | $-101M | $-93M | $-85M | $-97M | $-94M | $-92M | $-116M | $-117M | $-116M | $-119M | $-116M | $-116M | $-115M | $-113M | |
| Treasury Stock | $45M | $45M | $45M | $45M | $45M | $44M | $44M | · | $42M | $41M | $40M | $40M | $14M | $9M | $5M | $2M | |
| AOCI | $-20.8K | $-21.5K | $-24.1K | $-23.7K | $-23.9K | $-24.5K | $-23.3K | $-23.3K | $-23.5K | $-23.1K | $-24.1K | $-22.6K | $-23.0K | $-17.7K | $-15.2K | $-14.5K | |
| Stockholders' Equity | $33M | $38M | $35M | $44M | $52M | $40M | $43M | $48M | $28M | $31M | $37M | $43M | $73M | $77M | $81M | $86M | |
| Liabilities + Equity | $47M | $56M | $56M | $45M | $55M | $44M | $55M | $70M | $60M | $71M | $79M | $80M | $73M | $78M | $82M | $87M | |
| Shares Outstanding | 10,735,649 | 10,735,649 | · | 6,795,779 | 6,795,779 | 6,904,894 | 7,034,259 | 7,717,278 | 8,037,624 | 8,521,159 | 8,699,992 | 8,778,101 | 16,793,980 | 18,209,018 | 19,526,944 | 20,750,068 |
现金流 9
| 指标 | 趋势 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $0 | $771.5K | $60.5K | $60.5K | $0 | $-341.8K | $119.2K | $222.7K | $0 | $674.7K | $0 | $0 | $0 | $667 | $3.9K | $2.8K | |
| Operating Cash Flow | $-1M | $-786.8K | $-979.5K | $-2M | $-1M | $-509.9K | $-1M | $-373.3K | $-333.0K | $-177.1K | $-2M | $343.0K | $-288.4K | $-541.7K | $-2M | $-1M | |
| Investing Cash Flow | $0 | $5M | $-3M | $0 | $0 | $0 | $0 | $-7M | $0 | $-5M | $0 | $0 | $0 | $0 | $0 | $0 | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $-880 | $880 | |
| Stock Repurchased | $0 | $401.6K | $0 | $0 | $171.5K | $225.0K | $1M | $742.2K | $1M | $404.7K | $165.0K | $26M | $4M | $4M | $3M | $2M | |
| Net Stock Activity | · | · | · | $0 | · | · | · | $-742.2K | · | $-404.7K | $-165.0K | $-26M | · | · | · | $-2M | |
| Financing Cash Flow | $-169.8K | $543.8K | $6M | $0 | $-171.5K | $-4M | $-11M | $-10M | $-11M | $-7M | $748.7K | $6M | $-4M | $-4M | $-3M | $-2M | |
| Net Change in Cash | $-2M | $5M | $2M | $-2M | $-1M | $-4M | $-12M | $-18M | $-11M | $-12M | $-1M | $7M | $-5M | $-4M | $-5M | $-3M | |
| Taxes Paid | · | · | · | · | $0 | $0 | $0 | · | $0 | $0 | $0 | $1.6K | $0 | $0 | $0 | $0 |
盈利能力 2
| 指标 | 趋势 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | · | 1.5% | -13.4% | -14.5% | · | -5.3% | -2.2% | 31.2% | · | -0.83% | 3.5% | -3.8% | · | -0.90% | -2.1% | -3.3% | |
| ROE | · | 1.9% | -18.9% | -18.3% | · | -8.5% | -3.7% | 51.8% | · | -1.1% | 4.7% | -4.9% | · | -0.91% | -2.2% | -3.4% |
流动性与偿付能力 2
| 指标 | 趋势 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 12.3 | 14.6 | 18.0 | · | 14.2 | 4.5 | 4.4 | · | 8.2 | 14.1 | 49.2 | · | 88.0 | 58.9 | 75.5 | |
| Quick Ratio | · | 12.2 | 9.9 | 12.7 | · | 14.0 | 4.4 | 4.4 | · | 8.1 | 14.0 | 49.2 | · | 87.7 | 58.7 | 75.5 |
效率 1
| 指标 | 趋势 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 |
估值 (TTM) 8
| 指标 | 趋势 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | |
| Net Income TTM | · | $-18M | $-20M | $11M | · | $18M | $24M | $22M | · | $-2M | $-3M | $-7M | · | $-5M | $-5M | $-4M | |
| Market Cap | · | $9M | · | $7M | · | $11M | $13M | $15M | · | $19M | $18M | $23M | · | $53M | $57M | $50M | |
| P/E | · | -0.3 | -0.3 | -6.4 | · | 3.8 | 3.0 | 4.4 | · | -1.5 | -2.3 | -3.6 | · | -12.0 | -11.3 | -3.0 | |
| P/B | · | 0.2 | · | 0.2 | · | 0.3 | 0.3 | 0.3 | · | 0.6 | 0.5 | 0.5 | · | 0.7 | 0.7 | 0.6 | |
| P / Tangible Book | · | 0.2 | · | 0.2 | · | 0.3 | 0.3 | 0.3 | · | 0.7 | 0.6 | 0.6 | · | 0.7 | 0.7 | 0.6 | |
| P / Cash Flow | · | · | · | -3.5 | · | · | · | -40.5 | · | · | · | 68.1 | · | · | · | -45.7 | |
| Earnings Yield | · | -380.2% | -354.8% | -15.7% | · | 26.2% | 33.1% | 23.0% | · | -68.0% | -43.9% | -27.8% | · | -8.3% | -8.8% | -33.9% |
财务报表 损益表、资产负债表、现金流量表 — 年度,近5年
损益表
| 2026-04-30 | 2025-04-30 | 2024-04-30 | 2023-04-30 | 2022-04-30 | |
|---|---|---|---|---|---|
| 收入 | $0 | $0 | $0 | $0 | $0 |
| 净收入 | $-19M | $31M | $333.8K | $-4M | $-4M |
| 稀释后每股收益 (EPS) | $-2.77 | $3.19 | $-1.80 | $-0.22 | $-0.27 |
资产负债表
| 2026-04-30 | 2025-04-30 | 2024-04-30 | 2023-04-30 | 2022-04-30 | |
|---|---|---|---|---|---|
| 流动比率 | 45.3 | 7.7 | 6.8 | 116.2 | 121.4 |
| 速动比率 | 22.8 | 5.3 | 6.8 | 116.0 | 121.2 |
我的指标 您的个人关注列表 — 来自完整基本面的选定行
📊
选择对您重要的指标 — 点击上方完整基本面中任意行的 ➕。
您的选择已保存,并会跟随您浏览所有股票。
机构持有人 (13F) 37 家申报者 · $649K 总计 · 截至 2026年6月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸;单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存,而非方向性判断。
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 5 (-4 与上一季度对比) | 5 (+1 与上一季度对比) | 3 (-3 与上一季度对比) | 10 (+4 与上一季度对比) | -204K |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天,外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过,优先显示最近一个已完整报告的季度对。
公司内部人士 4 位内幕人士 · 0 位高管 · 4 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Michael M Abecassis | 董事 | 2026年3月31日 J | — | 0 | 0 | $0 |
| Jonathan Schechter | 董事 | 2026年3月31日 J | — | 0 | 0 | $0 |
| Wayne Remell Walker | 董事 | 2026年3月31日 J | — | 0 | 0 | $0 |
| Robert Weinstein | 董事 | 2026年3月31日 J | — | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士;净额=仅公开市场买卖
激进投资者及 5%+ 股东 3 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权,意图影响发行人(激进股东持股、董事会活动、并购)。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| PharmaCyte Biotech, Inc. ×2 申报 | 2025年11月18日 | 74.00% | 修订 | — | SEC |
| Iroquois Master Fund Ltd., Iroquois Capital Management, LLC, Iroquois Capital Investment Group LLC, Richard Abbe, Kimberly Page ×6 申报 | 2023年6月16日 | — | 初始申报 | — | SEC |
| Nima Montazeri (1) 2 (a) (b), Silver Rock Associates, Inc. (1) 2 (a) (b), Brown Stone Capital, LP (1) 2 (a) (b) ×2 申报 | 2020年7月29日 | — | 初始申报 | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF持仓 由 1 只交易所交易基金持有
权重仅反映直接股权持仓(N-PORT);杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| VXF · VANGUARD INDEX FUNDS | 0.00% | 56778 SH | 2026年8月8日 | 每日 |